Water-soluble carbon monoxide-releasing molecules: helping to elucidate the vascular activity of the 'silent killer'

被引:19
作者
Chatterjee, PK [1 ]
机构
[1] Univ Brighton, Dept Pharmacol & Therapeut, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England
关键词
carbon monoxide; carbon monoxide-releasing molecules; transition metal carbonyls; heame oxygenase; cardioprotection;
D O I
10.1038/sj.bjp.0705826
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carbon monoxide (CO) is formed during the degradation of haeme by haeme oxygenase (HO). As well as being an important signalling molecule and vasodilator, CO also possesses antihypertensive, anti-inflammatory and antiapoptotic qualities and protects against ischaemic tissue injury. Several approaches have been used to investigate the therapeutic potential of CO, ranging from direct administration of CO gas to the use of prodrugs, which generate CO upon metabolism. A novel approach involves the use of specific CO carriers, which will release measurable, controllable and effective amounts of CO into biological systems. Transitional metal carbonyls based around iron, manganese or ruthenium have recently been developed as CO-releasing molecules (CO-RMs) that, under appropriate conditions, will release CO. Such molecules have been shown to provide cardioproection in both ex vivo and in vivo experiments. To date, CO-RMs have been largely incompatible with biological systems in that they are only soluble in organic solvents or have to be preactivated either by physical or chemical stimuli. However, the recent development of water-soluble CO-RMs has provided new opportunities to investigate the pharmacological and biological features of CO without such confounding influences. CORM-3, a novel water-soluble CO-RM, has recently been used to ccnfirm the cardioprotective actions of CO. In this issue of British Journal of Pharmacology, Foresti and co-workers report that CORM-3 delivers CO, produces aortic vasodilation ex vivo and reduces blood pressure in vivo via modulation of the same cGMP and potassium channels utilised by endogenous and exogenous CO. These findings suggest that CORM-3 has the potential for use as a modulator of vascular function and hypertension. However, the use of water-soluble CO-RMs raises several questions of their own which will need to be addressed if CO-RMs are to be of future use therapeutically.
引用
收藏
页码:391 / 393
页数:3
相关论文
共 20 条
  • [1] Therapeutic applications of human heme oxygenase gene transfer and gene therapy
    Abraham, NG
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2003, 9 (30) : 2513 - 2524
  • [2] CARBON-MONOXIDE - KILLER TO BRAIN MESSENGER IN ONE-STEP
    BARINAGA, M
    [J]. SCIENCE, 1993, 259 (5093) : 309 - 309
  • [3] Carbon monoxide poisoning
    Blumenthal, I
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2001, 94 (06) : 270 - 272
  • [4] Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection
    Chauveau, C
    Bouchet, D
    Roussel, JC
    Mathieu, P
    Braudeau, C
    Renaudin, K
    Tesson, L
    Soulillou, JP
    Iyer, S
    Buelow, R
    Anegon, I
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2002, 2 (07) : 581 - 592
  • [5] Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule
    Clark, JE
    Naughton, P
    Shurey, S
    Green, CJ
    Johnson, TR
    Mann, BE
    Foresti, R
    Motterlini, R
    [J]. CIRCULATION RESEARCH, 2003, 93 (02) : E2 - E8
  • [6] Dulak J, 2003, ACTA BIOCHIM POL, V50, P31
  • [7] Vasoactive properties of CORM-3, a novel water-soluble carbon monoxide-releasing molecule
    Foresti, R
    Hammad, J
    Clark, JE
    Johnson, TR
    Mann, BE
    Friebe, A
    Green, CJ
    Motterlini, R
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2004, 142 (03) : 453 - 460
  • [8] Gassmann M, 2003, ADV EXP MED BIOL, V543, P323
  • [9] Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo
    Guo, YR
    Stein, AB
    Wu, WJ
    Tan, W
    Zhu, XP
    Li, QH
    Dawn, B
    Motterlini, R
    Bolli, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (05): : H1649 - H1653
  • [10] Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide - Implications for oxygen sensing and signaling
    Huang, LE
    Willmore, WG
    Gu, J
    Goldberg, MA
    Bunn, HF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 9038 - 9044